|
Match
|
Document |
Document Title |
|
|
5756467 |
Adipocyte differentiation inhibiting peptide and adipocyte differentiation inhibiting agent using the peptide as active component thereof
This invention aims to provide a peptide having an amino acid sequence of Val-Tyr-Pro or Val-Thr-Leu and having the ability to inhibit adipocyte differentiations, adipocyte differentiation...
|
|
|
5756700 |
Nucleic acid encoding human signal transducer and activator of transcription 4
The invention provides methods and compositions relating to interleukin 12 signal transducers, particularly an isolated human signal transducer and activator of transcription 4 (hStat 4), or a...
|
|
|
5753629 |
Distamycin A analogues as antitumour or antiviral agents
The present invention relates to compounds of formula (I) ##STR1## The compounds of the invention are useful as antitumor or antiviral agents.
|
|
|
5750648 |
Retroviral protease inhibitors and combinations thereof
The present invention is directed to the preparation and use of retroviral protease inhibitors and combinations of retroviral protease inhibitors which are effective in preventing the replication...
|
|
|
5747304 |
Fungicidal agents LL-15G256γ,δ, and ε produced by LL-15G256 (Hypoxylon oceanicum)
This invention provides new antifungal compounds of Formula I or II: ##STR1## wherein R, R 1 and R 2 are defined in the specification produced by culture LL-15G256 (Hypoxylon oceanicum), NRRL...
|
|
|
5747460 |
Method of treatment and prophylaxis of venous thrombosis
The invention relates to new competitive inhibitors of thrombin, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as...
|
|
|
5747459 |
Method for insuring adequate intracellular glutathione in tissue
A method is provided for increasing and/or maintaining the level of intracellular glutathione. Pursuant to the invention, compositions including denatured and at least partially hydrolyzed proteins...
|
|
|
5744451 |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
The present invention relates to N-substituted derivatives of glutamic acid of pharmaceutical interest, to pharmaceutical compositions which include compounds of the invention and pharmaceutically...
|
|
|
5739106 |
Appetite regulating compositions
Compositions and methods for reducing food intake, suppressing appetite and controlling body weight are provided. Such compositions may include an amylin agonist and a CCK agonist or a hybrid peptide.
|
|
|
5739280 |
Para-nitroanilide peptides
A compound of the formula R 1 --A 2 --A 1 -Asp-p-nitroanilide wherein: A 1 is a residue of any of the naturally occurring α-amino acids or a homolog, analog or derivative of a natural...
|
|
|
5739350 |
CC-1065 analogs
This invention provides some new synthetically obtained compounds of formula I and II ##STR1## which are useful as chemical intermediates. Representative formula I or II compounds have also been...
|
|
|
5736518 |
Peptide compounds of (L) amino acids and ring molecules, and therapeutical applications thereof
Compounds of general formula A--B--C in which: A is a monovalent radical of a L-ring molecule; B is a bivalent radical of a L-α-aminoacid; and C is a monovalent radical of a L-aromatic molecule....
|
|
|
5736521 |
Method of treatment and prophylaxis of arterial thrombosis
A method is disclosed for treatment or prophylaxis of arterial thrombosis employing the compound HOOC-CH 2 -(R)Cha-Pic-Nag or a stereoisomer thereof or a physiologically acceptable salt thereof.
|
|
|
5733881 |
Opioid peptide antagonists
Compounds of the formula I as well as methods for their preparation, their pharmaceutical preparations and their use. ##STR1## The compounds of formula I are useful in therapy, especially as...
|
|
|
5731413 |
Method of synthesis of peptidyl aldehydes
This invention provides solution-phase and solid-phase methods for the synthesis of peptidyl argininals and to novel! reagents useful therein.
|
|
|
5726158 |
Peptide derivatives
The invention concerns pharmaceutically useful trifluoromethyl ketone substituted di-, tri- and tetra-peptide derivatives of the formulae Ia, Ib, Ic set out hereinafter, and salts thereof, which...
|
|
|
5723442 |
Peptide derivatives
The present invention relates to certain peptide derivatives, as described herein, which are human leukocyte elastase (HLE) inhibitors making them useful whenever such inhibition is desired, such...
|
|
|
5714580 |
Trypsin Inhibitors
Novel compounds having activity against trypsin are disclosed. Specifically, novel peptide aldehyde analogues that have substantial potency and specificity as inhibitors of mammalian pancreatic...
|
|
|
5710247 |
Process and intermediates for the synthesis of LHRH antagonists
A method is provided for preparing decapeptide and undecapeptide derivatives of LHRH by solution phase peptide chemistry as well as intermediate peptides useful in the same method.
|
|
|
5710256 |
Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
The present invention is directed to novel methadone derivatives which are synthesized for the covalent attachment to antigens (proteins or polypeptides) for the preparation of antibodies or...
|
|
|
5707965 |
Peptides for control of intestinal motility
Peptides isolated from the bovine posterior pituitary gland are useful for the control of intestinal motility.
|
|
|
5705607 |
Procedures for the isolation and titration of sarcocystine or parasite toxin of sarcocystis genus
The present invention provides the technique for isolating the toxin of the Sarcocystis protozoa, which may be later used in the production of specific antibodies against the sarcocystine...
|
|
|
5703050 |
Urea derivatives, their preparation and use
Urea derivates are disclosed having the formula (I). ##STR1## in which A, B, W, Z, R, R 1 , R 2 , R 3 and r have the meaning given in the description, as well as a process for preparing the same...
|
|
|
5703208 |
3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
The present invention discloses peptide aldehydes which are potent and specific inhibitors of thrombin, their pharmaceutically acceptable salts, pharmaceutically acceptable compositions thereof,...
|
|
|
5700780 |
Antiviral peptide derivatives having a 2-oxoalkyl amino acid side chain
Disclosed herein are peptide derivatives of the formula X --NR 1 --CH(R 2 )--C(W 1 )! n --NH--CR 3 (R 4 )--C(W 2 )--NR 5 --CH CH 2 C(O)--Y!--C(W 3 )--NH--CR 6 -- CR 7 --(R 8 )--COOH!--C(W 4...
|
|
|
5698674 |
Triheterocyclic peptides capable of binding the minor and major grooves of DNA
The present invention provides a triheterocyclic peptide having first, second, and third 5-member heterocyclic moieties having the following formula CR 3 CONH--Q 1 --CONH--Q 2 --CONH--Q 3 ...
|
|
|
5696134 |
Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
Novel cis-epoxide compounds of formula (I) are useful for treating or preventing diseases caused by HIV infection: ##STR1## wherein A, B, R 1 to R 4 and n have the same meanings as defined in the...
|
|
|
5693617 |
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
Disclosed herein is a method for reducing the rate of degradation of proteins in an animal comprising contacting cells of the animal with certain proteasome inhibitors. The structure of the...
|
|
|
5691315 |
Endothelin antagonistic peptide derivatives
The invention relates to compounds which are antagonists of endothelin, to processes for their preparation, and to their use as pharmaceuticals. The compounds of the invention are Useful in the...
|
|
|
5686420 |
Thyrotropin-releasing hormone analogs and method of use
A series of novel thyrotropin-releasing hormone analogs wherein the C-terminal prolineamide moiety has been preserved, the N-terminal moiety comprises one of five different ring structures and the...
|
|
|
5686421 |
Hydantoin derivates
Hydantoin derivatives of the formula I ##STR1## in which n is 3 or 4, R 1 is alkyl or a radical of the formula R'--NH--CN--R" with R' and R" being hydrogen or alkyl, and R 2 is hydrogen,...
|
|
|
5686423 |
Di-and tri-peptide mimetic compounds for Parkinson's disease
A series of di- and tri-peptide mimetic dopamine prodrugs are synthesized in which D-phenylglycine or D-p-hydroxyphenylglycine is attached as tools for delivery of L-dopa through the intestine via...
|
|
|
5681927 |
Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
Chelated radionuclide compositions are provided for conjugation to polypeptides and carbohydrates. The resulting conjugates may be used in diagnosis and therapy.
|
|
|
5677282 |
Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase
Amino acid amides of 5-amino-1,3,4-thiadiazole-2-thione are disclosed. These compounds inhibit matrix metalloproteinase enzymes and cartilage degradation. Methods of treating diseases caused by...
|
|
|
5677281 |
Use of peptide derivatives for the preparation of medicaments inhibiting endopeptidases 24.15 and 24.16
The invention relates to the use of peptide derivatives for the preparation of medicaments inhibiting endopeptidases 24.15 and 24.16. These peptide derivatives are in accordance with the formula:...
|
|
|
5674848 |
Bioreactor compositions with enhanced cell binding
Compositions of the invention include packing materials having compounds thereon with enhanced cell binding with respect to collagen. These packing materials are useful for in vitro uses such as...
|
|
|
5672586 |
Herpes ribonucleotide reductase inhibitors
Disclosed herein are compounds of the formula ##STR1## wherein R 1 is hydrogen or (1-4C) alkyl, R 2 is (1-4C) alkyl or a therapeutically acceptable salt thereof. The compounds are useful for...
|
|
|
5672582 |
Thrombin inhibitors
4-substituted cyclohexylamine derivatives which are thrombin catalytic site inhibitors and which are useful as anticoagulants. These compounds show selectivity for thrombin over other trypsin-like...
|
|
|
5670133 |
Peptides method for radiolabeling them, and method for detecting inflammation
High affinity chemotactic peptides containing a biological-function domain and a medically useful metal ion-binding domain are labeled with medically useful metal ions for use in diagnosis and...
|
|
|
5663296 |
Hydroxamate inhibitors of endothelin converting enzyme
Hydroxamate compounds of the following formula are disclosed: R--AA 3 --AA 4 --AA 5 --AA 6 --NH--OR 2 wherein AA 3 --AA 6 represent amino acid residues. The disclosed compounds are...
|
|
|
5663148 |
Anaphylatoxin receptor ligands containing lipophilic residues
Oligopeptide compounds or oligopeptide analague compounds of the formula, A-B-D-E-G-J-L-M-N(R 4 )Arg-OH, which are ligands for the anaphylatoxin receptor and are useful in the treatment of...
|
|
|
5663297 |
Antithrombic peptides
Disclosed herein are peptide of the formula R--CONH--CH 2 --CONH--CH(R')--CH 2 COOH I wherein R and R' are as defined herein. The claimed peptide derivatives inhibit platelet...
|
|
|
5663139 |
Inhibitors of retroviral proteases
The present invention relates to a compound of the formula ##STR1## in which A, Q, R 2 , R 3 and R 4 , and also the corresponding, asterisked radicals, are defined as indicated in the description,...
|
|
|
5663150 |
Cyclopentane-β-amino acid tripeptides
The present invention relates to cyclopentane-β-amino acid tripeptides, a process for their preparation and their use as antimicrobial, in particular antimycotic, medicaments.
|
|
|
5661129 |
Organic nitrates containing a disulfide group as cardiovascular agents
The invention relates to novel nitrates containing a disulphide group, and to processes for their preparation. The compounds can be used for the therapy of disorders of the cardiovascular system.
|
|
|
5658885 |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
This invention relates to Novel α-aminoacid and α-aminoboronic acid and corresponding peptide analogs of the following formula: ##STR1##
|
|
|
5656604 |
Peptide compound and its preparation
Peptide compounds of the formula (I') ##STR1## in which R 1 is acyl, R 2 is lower alkyl, cyclo(lower)alkyl(lower)alkyl or optionally substituted heterocyclic(lower)alkyl, R 3 is optionally...
|
|
|
5652220 |
Encapsulation of TRH or its analog
The present invention relates to a microcapsule containing TRH, its analog or a salt thereof and a method of producing the same which attains the release of the active ingredient stably for a...
|
|
|
5650393 |
Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
Amphiphilic derivatives of amino acids or peptides are provided, comprising a polyhydroxylated hydrophilic part derived from a sugar, from a polyol, from an aminopolyol or from an oligosaccharide,...
|
|
|
5646121 |
Pseudopeptides with antiviral activity
The present invention relates to novel pseudopeptides with antiviral activity of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to a process...
|